Scott Hirsch

Scott Hirsch has over 20 years of experience in healthcare operations, investment management, and financial services, including his most recent role of Interim CEO at Endo, Inc., where he was a board member prior to stepping into the CEO position.

Mr. Hirsch has served as an executive operator and board member for privately held companies within Blackstone, Bain Capital, and Lauder Partner portfolios. He was formerly the CEO of Solta Medical, where he led the business growth, investment cycle, and global infrastructure development for a healthcare company operating in over 50 countries. Prior to Solta, Mr. Hirsch was the President of the Ortho Dermatologics and OraPharma business segments and the Chief Business Officer of Bausch Health/Bausch & Lomb. He additionally held the role of President of the Bausch Foundation and Patient Access. Prior to Bausch, Mr. Hirsch was a Portfolio Manager at Citadel’s Surveyor Capital fund, overseeing investment and risk management decisions for a healthcare portfolio.

Mr. Hirsch started on Wall Street in the investment banking group of Credit Suisse, where he was recognized by Institutional Investor magazine as a top equity research analyst covering specialty pharmaceuticals, biotechnology, and global generics companies. Mr. Hirsch began his career as a venture capital operator in product development, sales, and marketing roles at J.P. Morgan Partners and Morgan Stanley Ventures portfolio companies including Medsite, a healthcare technology company that was acquired by WebMD.

Mr. Hirsch holds an MBA in Healthcare Management and Finance from The Wharton School and BFA with honors from The Rhode Island School of Design.